Chronic Lymphocytic Leukaemia (CLL) TP53 mutation analysis (Pilot)
Pilot - Not Accredited
Chronic Lymphocytic Leukaemia (CLL) TP53
PURPOSE OF PROGRAMME:
Analysis for TP53 mutation status in chronic lymphocytic leukaemia samples: DNA and lyophilised cells.
MATERIAL PROVIDED: Cells: lyophilised, DNA in TE buffer
DISTRIBUTIONS PER YEAR: 1
SAMPLES PER DISTRIBUTION: 3
FREQUENCY OF DISTRIBUTION: 1
PROGRAMME OF ANALYSIS:
TP53 variant detection
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA